Eva Novotná

Years Active: 2017-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Lucie Čermáková, Jakub Hofman, Lenka Laštovičková, Lucie Havlíčková, Ivona Špringrová, Eva Novotná, Vladimír Wsól
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux. Pharmaceutics 14 (10) (2022)
Eva Novotná, Karel Waisser, Jiří Kuneš, Karel Palát, Lenka Skálová, Barbora Szotáková, Vladimír Buchta, Jiřina Stolaříková, Vít Ulmann, Marcela Pávová, Jan Weber, Jitka Komrsková, Pavlína Hašková, Ivan Vokřál, Vladimír Wsól
Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity. Archiv der Pharmazie 350 (8) (2017)

Eva Novotná.css-eqlu8i{font-size:small;padding-left:4px;}